ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

To Wait or Not to Wait: The Survival Benefit of Preemptive Kidney Transplantation after Accounting for Lead Time Bias

S. Yu1, A. Kernodle1, J. Snyder2, J. Garonzik-Wang1, D. Segev1, A. Massie1

1Johns Hopkins, Baltimore, MD, 2SRTR, Minneapolis, MN

Meeting: 2020 American Transplant Congress

Abstract number: C-079

Keywords: Kidney transplantation, Mortality

Session Information

Session Name: Poster Session C: Kidney Living Donor: Long Term Outcomes

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Over 2,000 preemptive living donor kidney transplants (LDKT) per year are performed in the US. Preemptive LDKT allows recipients to avoid dialysis, but increases exposure to immunosuppression and burdens donors with longer exposure to nephrectomy. Most prior studies of the survival benefit of preemptive transplantation have failed to appropriately account for lead time, the unmeasured time between chronic kidney disease and transplantation. We sought to quantify the survival benefit of preemptive LDKT compared to waiting for an early LKDT (within 6 months of dialysis) after accounting for lead time bias.

*Methods: Using SRTR data, we studied 120,020 adult, preemptively listed kidney-only transplant (KT) candidates 2000-2017. To account for lead time bias, 27,839 preemptive LDKT recipients were 1:1 matched based on accumulated wait time to waitlist registrants who were dialysis-free at time of matching. Matched waitlist controls were censored 6 months after dialysis if not transplanted. We used Cox regression to compare the mortality risk between the two groups, with inverse probability weighting to account for confounding by candidate characteristics (age, sex, race, BMI, ESRD diagnosis, education, year of listing, and eGFR at listing).

*Results: Compared to waitlist controls, preemptive LDKT recipients were more likely to be younger, white, male, had lower BMI, and lower eGFR at listing. After weighting, there was no evidence of difference in mortality risk among preemptive LDKT recipients compared to waitlist controls (weighted HR: 0.84 0.92 1.01, P=0.1, Figure).

*Conclusions: Our findings provide no evidence that preemptive LDKT is associated with a survival benefit after accounting for lead time bias. The best timing for LDKT should be determined by risks and benefits to the donor and recipient, but not only based on a perception of survival benefit.

 border=

The characteristics of LDKT recipients and their matched waitlist candidates
Characteristics

Preemptive transplant recipient

(N=27,839)

Matched waitlist candidates

(N=27,839)

P-value
Age at Listing, median (IQR) 49 (38, 59) 55 (45, 63) <0.001
Male 59.1% 55.9% <0.001
African American 8.1% 17.7% <0.001
BMI, median (IQR) 27 (24, 31) 28 (25, 33) <0.001
eGFR at listing, median (IQR) 13 (10, 17) 15 (12, 19) <0.001
Peak PRA, median (IQR) 0 (0, 2) 0 (0, 9) <0.001
  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Yu S, Kernodle A, Snyder J, Garonzik-Wang J, Segev D, Massie A. To Wait or Not to Wait: The Survival Benefit of Preemptive Kidney Transplantation after Accounting for Lead Time Bias [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/to-wait-or-not-to-wait-the-survival-benefit-of-preemptive-kidney-transplantation-after-accounting-for-lead-time-bias/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences